Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification

作者: Rodney N. Wiltshire , B.K. Ahmed Rasheed , Henry S. Friedman , Allan H. Friedman , Sandra H. Bigner

DOI: 10.1093/NEUONC/2.3.164

关键词:

摘要: Cytogenetic and molecular genetic studies of glioblastoma multiforme (GBM) have shown that the most frequent alterations are gains chromosome 7, losses 9p loci 10, gene amplie cation, primarily epidermal growth factor receptor ( EGFR) gene. Although this proe le is potentially useful in distinguishing GBM from other tumor types, techniques used tend to be labor intensive, some can detect only or loci. Comparative genomic hybridization (CGH) a powerful technique capable identifying both DNA sequences. The present study compares CGH evaluation 22 with classic cytogenetics, loss heterozygosity by allelotyping, cation Southern blot analysis determine reliability characterization GBM. karyotypic data were consistent showing gain 7 accompanied 10 as abnormality, followed 17 cases. Loss chromosomes (19/22) (9/22) cone rmed underrepresentation CGH. Genomic cations observed 5 cases where was detected analysis. show equally reliable, compared more established methods, for recognizing prominent associated support its use plausible adjunct glioma classie cation. Neuro-Oncology 2, 164-173, 2000

参考文章(59)
Maria Dȩbiec-Rychter, Janusz Alwasiak, Paweł P. Liberski, Bogusław Nedoszytko, Małgorzata Babińska, Krzysztof Mrózek, Brunon Imieliński, Jolanta Borowska-Lehman, Janusz Limon, Accumulation of chromosomal changes in human glioma progression: A cytogenetic study of 50 cases Cancer Genetics and Cytogenetics. ,vol. 85, pp. 61- 67 ,(1995) , 10.1016/0165-4608(95)00129-8
T. Cremer, M. Kiessling, R. G. Weber, F. K. Albert, C. Sommer, Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Laboratory Investigation. ,vol. 74, pp. 108- 119 ,(1996)
McLendon Re, Bigner Dd, Fuchs He, Friedman Ah, Rasheed Bk, Bigner Sh, Friedman Hs, Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene. ,vol. 10, pp. 2243- 2246 ,(1995)
Vijayanagaram S. Venkatraj, Martin Begemann, Antonio Sobrino, Jeffrey N. Bruce, I. Bernard Weinstein, Dorothy Warburton, Genomic changes in glioblastoma cell lines detected by comparative genomic hybridization. Journal of Neuro-oncology. ,vol. 36, pp. 141- 148 ,(1998) , 10.1023/A:1005859318971
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
Carolyn A. Pedone, Dan Fults, Ray White, Ray White, Gregory A. Thomas, Allelotype of human malignant astrocytoma. Cancer Research. ,vol. 50, pp. 5784- 5789 ,(1990)
P. Kleihues, Webster K Cavenee, None, Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer. ,(2000)
Gaetano Finocchiaro, Cristiana Giani, Mutation Rate of the CDKN2 Gene in Malignant Gliomas Cancer Research. ,vol. 54, pp. 6338- 6339 ,(1994)
R Godbout, J He, MJ Allalunis-Turner, rd Rs Day, VP Collins, JR Allen, CD James, CDK4 Amplification Is an Alternative Mechanism to p16 Gene Homozygous Deletion in Glioma Cell Lines Cancer Research. ,vol. 54, pp. 5804- 5807 ,(1994)